Yanyu Zhang

Prof. Yanyu Zhang

Fourth Military Medical University, Shanxi, China
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2017 in Energies
Verified
Journal Article
Open access
PDF file
Xiaofei SunXiaofei Sun
Xiaofei Sun
Yanyu ZhangYanyu Zhang
Yanyu Zhang
GCGuangpeng Chen
Guangpeng Chen
ZGZhiyong Gai
Zhiyong Gai
The injected fluids in secondary processes supplement the natural energy present in the reservoir to displace oil. The recovery efficiency mainly depends on the mechanism of pressure maintenance. However, the injected fluids in tertiary or enhanced oil recovery (EOR) processes interact with the reservoir rock/oil system. Thus, EOR techniques are receiving substantial attention worldwide as the available oil resources are declining. However, some challenges, such as low sweep efficiency, high costs and potential formation damage, still hinder the further application of these EOR technologies. Current studies on nanoparticles are seen as potential solutions to most of the challenges associated with these traditional EOR techniques. This paper provides an overview of the latest studies about the use of nanoparticles to enhance oil recovery and paves the way for researchers who are interested in the integration of these progresses. The first part of this paper addresses studies about the major EOR mechanisms of nanoparticles used in the forms of nanofluids, nanoemulsions and nanocatalysts, including disjoining pressure, viscosity increase of injection fluids, preventing asphaltene precipitation, wettability alteration and interfacial tension reduction. This part is followed by a review of the most important research regarding various novel nano-assisted EOR methods where nanoparticles are used to target various existing thermal, chemical and gas methods. Finally, this review identifies the challenges and opportunities for future study regarding application of nanoparticles in EOR processes.

30 June 2015 in Cancer Research
Verified
Journal Article
Open access
PDF file
JCJessica Cedervall
Jessica Cedervall
Yanyu ZhangYanyu Zhang
Yanyu Zhang
HHHua Huang
Hua Huang
LZLei Zhang
Lei Zhang
JFJulia Femel
Julia Femel
AOAnna-Karin Olsson
Anna-Karin Olsson
Cancer produces a variety of collateral effects in patients beyond the malignancy itself, including threats to distal organ functions. However, the basis for such effects, associated with either primary or metastatic tumors, are generally poorly understood. In this study, we show how heart and kidney vascular function is impaired by neutrophils that accumulate in those tissues as a result of tumor formation in two different transgenic mouse models of cancer (RIP1-Tag2 model of insulinoma and MMTV-PyMT model of breast cancer). Neutrophil depletion by systemic administration of an anti-Gr1 antibody improved vascular perfusion and prevented vascular leakage in kidney vessels. We also observed the accumulation of platelet–neutrophil complexes, a signature of neutrophil extracellular traps (NET), in the kidneys of tumor-bearing mice that were completely absent from healthy nontumor-bearing littermates. NET accumulation in the vasculature was associated with upregulation of the proinflammatory adhesion molecules ICAM-1, VCAM-1, and E-selectin, as well as the proinflammatory cytokines IL1β, IL6, and the chemokine CXCL1. Administering DNase I to dissolve NETs, which have a high DNA content, restored perfusion in the kidney and heart to levels seen in nontumor-bearing mice, and also prevented vessel leakage in the blood vasculature of these organs. Taken together, our findings strongly suggest that NETs mediate the negative collateral effects of tumors on distal organs, acting to impair vascular function, and to heighten inflammation at these sites. Cancer Res; 75(13); 2653–62. ©2015 AACR.

9 August 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
YXYuan Xie
Yuan Xie
LHLiqun He
Liqun He
RLRoberta Lugano
Roberta Lugano
Yanyu ZhangYanyu Zhang
Yanyu Zhang
TRTingting Ren
Tingting Ren
LZLei Zhang
Lei Zhang
Passage of systemically delivered pharmacological agents into the brain is largely blocked by the blood-brain-barrier (BBB), an organotypic specialization of brain endothelial cells (ECs). Tumor vessels in glioblastoma (GBM), the most common malignant brain tumor in humans, are abnormally permeable, but this phenotype is heterogeneous and may differ between the tumor’s center and invasive front. Here, through single-cell RNA sequencing (scRNA-seq) of freshly isolated ECs from human glioblastoma and paired tumor peripheral tissues, we have constructed a molecular atlas of human brain ECs providing unprecedented molecular insight into the heterogeneity of the human BBB and its molecular alteration in glioblastoma. We identified 5 distinct EC phenotypes representing different states of EC activation and BBB impairment, and associated with different anatomical locations within and around the tumor. This unique data resource provides key information for designing rational therapeutic regimens and optimizing drug delivery.

31 July 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
JCJessica Cedervall
Jessica Cedervall
Yanyu ZhangYanyu Zhang
Yanyu Zhang
AOAnna-Karin Olsson
Anna-Karin Olsson
A large proportion of cancer-related deaths are caused by thrombosis and general organ failure. One example is acute renal failure, a major cause of morbidity and mortality in cancer patients. Surprisingly, however, little is known about the situation in organs that are not targets for metastasis or affected by the primary tumor. Recently, neutrophil extracellular traps (NET) were implicated in tumor-induced effects on distant organs unaffected by the actual tumor cells. Formation of NETs (NETosis) was identified a decade ago as a mechanism by which the innate immune system protects us from infections, especially in situations with sepsis. NETs are formed when neutrophils externalize their nuclear DNA together with antimicrobial granule proteins and form a web-like structure that can trap and kill microbes. It is now becoming increasingly clear that NETs also form under noninfectious inflammatory conditions like cancer, thrombosis, autoimmunity, and diabetes and significantly contribute to disease development. The existence of NET-dissolving drugs like heparin and DNase I, already in clinical use, and recent development of specific inhibitors of protein-arginine deiminase 4 (PAD4), an enzyme required for NET formation, should enable clinical targeting of NETosis. Preventing NETosis in cancer could provide a strategy to counteract tumor-induced thrombosis and organ failure as well as to suppress metastasis. Cancer Res; 1–5. ©2016 AACR.

14 August 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
Yanyu ZhangYanyu Zhang
Yanyu Zhang
JCJessica Cedervall
Jessica Cedervall
AHAnahita Hamidi
Anahita Hamidi
MHMelanie Herre
Melanie Herre
KVKati Viitaniemi
Kati Viitaniemi
AOAnna-Karin Olsson
Anna-Karin Olsson
Platelet-derived growth factor B (PDGFB) plays a crucial role in recruitment of PDGF receptor β–positive pericytes to blood vessels. The endothelium is an essential source of PDGFB in this process. Platelets constitute a major reservoir of PDGFB and are continuously activated in the tumor microenvironment, exposing tumors to the plethora of growth factors contained in platelet granules. Here, we show that tumor vascular function, as well as pericyte coverage is significantly impaired in mice with conditional knockout of PDGFB in platelets. A lack of PDGFB in platelets led to enhanced hypoxia and epithelial-to-mesenchymal transition in the primary tumors, elevated levels of circulating tumor cells, and increased spontaneous metastasis to the liver or lungs in two mouse models. These findings establish a previously unknown role for platelet-derived PDGFB, whereby it promotes and maintains vascular integrity in the tumor microenvironment by contributing to the recruitment of pericytes. Significance: Conditional knockout of PDGFB in platelets demonstrates its previously unknown role in the maintenance of tumor vascular integrity and host protection against metastasis.

7 April 2017 in OncoImmunology
Verified
Journal Article
Closed access
JCJessica Cedervall
Jessica Cedervall
ADAnca Dragomir
Anca Dragomir
FSFalk Saupe
Falk Saupe
Yanyu ZhangYanyu Zhang
Yanyu Zhang
JÄJohan Ärnlöv
Johan Ärnlöv
AOAnna-Karin Olsson
Anna-Karin Olsson
Renal insufficiency is a frequent cancer-associated problem affecting more than half of all cancer patients at the time of diagnosis. To minimize nephrotoxic effects the dosage of anticancer drugs are reduced in these patients, leading to sub-optimal treatment efficacy. Despite the severity of this cancer-associated pathology, the molecular mechanisms, as well as therapeutic options, are still largely lacking. We here show that formation of intravascular tumor-induced neutrophil extracellular traps (NETs) is a cause of kidney injury in tumor-bearing mice. Analysis of clinical biomarkers for kidney function revealed impaired creatinine clearance and elevated total protein levels in urine from tumor-bearing mice. Electron microscopy analysis of the kidneys from mice with cancer showed reversible pathological signs such as mesangial hypercellularity, while permanent damage such as fibrosis or necrosis was not observed. Removal of NETs by treatment with DNase I, or pharmacological inhibition of the enzyme peptidylarginine deiminase 4 (PAD4), was sufficient to restore renal function in mice with cancer. Tumor-induced systemic inflammation and impaired perfusion of peripheral vessels could be reverted by the PAD4 inhibitor. In conclusion, the current study identifies NETosis as a previously unknown cause of cancer-associated renal dysfunction and describes a novel promising approach to prevent renal failure in individuals with cancer.